Fesoterodine Fumarate

CHEMBL1201765 Phase 4 Đã phê duyệt Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

527.6 g/mol

LogP

—

Phase

4

This fumarate salt form of fesoterodine is used to treat overactive bladder by blocking the nerve signals that cause sudden, uncontrollable urges to urinate. It is the active form delivered in extended-release tablets to provide consistent symptom control throughout the day.

Khối lượng phân tử

527,6000 g/mol

TPSA

124,00 Å²

Cơ chế tác dụng

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Cấu trúc 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)/C=C/C(=O)O

InChI

InChI=1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1

Molecular Formula

C30H41NO7

HBD / HBA

3 / 8

Liên kết có thể quay

13

Nguyên tử nặng

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This fumarate salt form of fesoterodine is used to treat overactive bladder by blocking the nerve signals that cause sudden, uncontrollable urges to urinate. It is the active form delivered in extended-release tablets to provide consistent symptom control throughout the day.

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Yes, Fesoterodine Fumarate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201765. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9849808. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Bạn đang tìm kiếm thông tin thân thiện với bệnh nhân?

Fesoterodine Fumarate trên PillFYI

Cấu trúc

Dữ liệu nhanh

Công thức: C30H41NO7
Tên đồng nghĩa: 1

Liên kết ngoài

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Fesoterodine Fumarate

Cơ chế tác dụng

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

Cite this structure

Embed this structure

No targets recorded

No interactions recorded

No side effects recorded

Câu hỏi thường gặp

References & Data Sources

Embed This Widget